Taken together these data highlight the highly specific nature of the cancer-cell-specific killing following Cdc7 targeting and therefore make it a potentially powerful target in the treatment of advanced pancreatic cancer. The gene discussed is CDC7; the disease is familial pancreatic carcinoma.